Advertisements



We are Sorry, This Page doesn't Exist


Karnataka polls: Is BJP more efficient in translating votes into seats?

Opinion polls in Karnataka are looking fuzzy as of now, and like Gujarat, only the day of the result will tell us which way the pendulum swings.....»»

Category: topSource: business-standardMay 6th, 2018

Concurrent Lok Sabha and assembly polls can be held in 2 phases: Law panel

The first phase of simultaneous polls can take place in 2019, and second one in 2024 the panel said.....»»

Category: topSource: business-standardApr 11th, 2018

Inter-state e-way bill to be rolled out in five states from April 15

The five states which would form part of the first phase are Andhra Pradesh, Telangana, Gujarat, Kerala and Uttar Pradesh.....»»

Category: topSource: business-standardApr 10th, 2018

Justice Department Wants to Speed Appeal of AT&T-Time Warner Deal

The Justice Department on Wednesday sought to fast-track its appeal of the court decision allowing AT&T to buy Time Warner, while offering the first hints of its legal arguments for the next phase of proceedings......»»

Category: smallbizSource: wsj2 hr. 50 min. ago

Cellectar Biosciences reports "positive" Phase 2 interim data for CLR 131

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall15 hr. 20 min. ago

J&J"s (JNJ) Phase III Study for Invokana Halted Earlier

Johnson & Johnson's (JNJ) phase III CREDENCE study evaluating the efficacy and safety of its diabetes drug Invokana is being stopped early based on positive pre-specified efficacy data. Johnson & Johnson JNJ .....»»

Category: personnelSource: nytJul 17th, 2018

Neurotrope Returns After "Failed" Alzheimer"s Trial, But Has Anything Changed?

Neurotrope Inc (NASDAQ: NTRP) announced Monday that it has initiated enrollment for a confirmatory Phase 2 study of read more.....»»

Category: blogSource: benzingaJul 17th, 2018

Cellectar Biosciences shares surge 15% on results of one cancer patient in mid-stage trial

Cellectar Biosciences Inc. shares rose 15% in Tuesday trade after the company announced that one patient in a phase 2 trial for its cancer therapy had a major improvement in the amount of tumor material in her body, or an about 94% reduction. The tr.....»»

Category: topSource: marketwatchJul 17th, 2018

AbleTo hires new CEO from CVS

AbleTo, a Manhattan behavioral health startup that has raised $65.8 million, has hired Trip Hofer from CVS' specialty pharmacy division to lead the company into its next phase as it looks to add more... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkJul 17th, 2018

Viking Therapeutics announces VK5211 Phase 2 study results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 17th, 2018

Ironwood Begins New Phase III Study to Expand Linzess Label

Ironwood (IRWD) commences a phase IIIb study in order to add a couple of new symptoms like bloating and discomfort associated with IBS-C to Linzess' label. Ironwood Pharmaceuticals, Inc. IRWD announced that it .....»»

Category: personnelSource: nytJul 17th, 2018

Arcus Biosciences announces final data from Phase 1 trial for AB928

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 17th, 2018

Asterias provides six month data readout for AST-OPC1 Phase 1/2a clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 17th, 2018

Omeros initiates dosing in Phase 1 trial for OMS527 targeting addiction

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 17th, 2018

AC Immune says second Phase 2 trial of crenezumab fully recruited

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 17th, 2018

Genentech says Phase III CAPSTONE-2 study met primary objective

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 17th, 2018

Aveo drops 16% to $2.38 after pushing out Phase 3 readout

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 16th, 2018

United Airlines buying four more Dreamliners and 25 Embraer E175s

United says new Dreamliners – the 787-9 variant – will help phase out older widebody jets in its fleet. The Embraers will replace CRJ 700 regional jets. &#.....»»

Category: topSource: usatodayJul 16th, 2018

Pfizer initiates pivotal Phase 3 program for hemophilia B gene therapy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 16th, 2018

Neurotrope enrolls first patient into confirmatory Phase 2 trial of Bryostatin-1

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 16th, 2018